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ABSTRACT 
BACKGROUND 
It has been found that HIV infection predisposes to a hypercoagulable state and that the risk 
of venous thromboembolism is about 10times that expected among people without HIV. 
Deep vein thrombosis (DVT) has been reported to be more common among HIV infected 
people in several parts of the country. No formal research has been published to confirm or 
refute this observation within the South African context. There has thus been the need to 
determine the true prevalence of deep vein thrombosis among patients with HIV infection in 
the medical ward of Nelson Mandela Hospital, Mthatha, South Africa. 
AIM; 
To determine the risk profile and prevalence of Deep Venous Thrombosis (DVT) in patients 
admitted with HIV/AIDS at the Nelson Mandela Hospital. 
OBJECTIVES; 
The main objectives of this study were: 
 To determine the proportion of patients admitted with DVT who also had HIV/AIDS.
 To obtain a profile of the risk factors associated with DVT in patients requiring
admission for DVT.
 To describe the association of DVT and HIV/AIDS in subgroups of patients with
different degrees of immunosuppression.
METHODS 
We conducted a study in which we collected data retrospectively on all DVT cases admitted 
over a year period. Detailed information was collected about HIV status,CD4 count, and 
other risk factors for DVT. 
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RESULTS 
 
A total of 102 DVT cases were admitted over the period of one year and data was extracted 
from the charts. A total of 81 (79.4%) of the DVT cases were HIV infected (HIV positive) 
while 21 cases(20.6%) were HIV negative. Among the other risk factors for DVT considered, 
42(41.2%) of the DVT cases were also on treatment for Tuberculosis. Only a small 
percentage of the DVT cases had co morbidities like obesity,smoking,cancer,diabetes, 
immobility, kidney disease etc.It was found that 70(68.6%) of DVT cases were < 40yrs of 
age. Among patients with known CD4 counts, 29(70.7%) had a CD4 count<200 while 12 
(29.3%) had a CD4 count ≥ 200. In univariate analysis, HIV (OR = 11.571;95% CI = 4.888 – 
27.392)  and TB (OR = 1.667.CI = 1.420 – 1.956) had significant association with 
DVT.When subjected to multiple logistic regression, only HIV (OR = 13.2, 95% CI = 5.3 – 
32.3;p = <0.0001) and Age < 40yrs (OR = 2.7, 95%CI = 1.1 – 6.7; p = 0.034) were 
statistically significantly associated with DVT.A total of 650 HIV related cases were 
admitted over the same year period which gave a cumulative period prevalence of DVT of 
12.5% among the HIV infected population. 
 
CONCLUSION 
 
The prevalence of DVT at the Nelson Mandela hospital Mthatha was 12.5% for the year 2009 
and is clearly above the average reported in other studies. HIV infection and age were the risk 
factors with a statistically significant association with DVT in this study. As this was an 
observational cross-sectional study, a more definitive prospective longitudinal design would 
assist in establishing the incidence of DVT in HIV infected patients, as well as the magnitude 
of the relationship between HIV and DVT. 
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CHAPTER ONE 
 
 
INTRODUCTION AND MOTIVATION 
 
There is reason to believe that the number of patients being admitted with Deep Vein 
Thrombosis in our hospital recently has increased compared with past records. Many patients 
have also been admitted with pulmonary embolism some of which were actually diagnosed at 
autopsy. 
 
Of note is that most of these patients admitted either with DVT or thrombosis at other sites 
are also infected with Human Immunodeficiency Virus (HIV). Although some of them have 
other risk factors for thrombosis like obesity, infections (e.g. Tuberculosis) etc, the 
relationship between thrombosis and HIV infection has been documented by many 
researchers. It has been documented that HIV infection predispose to a hypercoagulable state 
which increases their risk of developing thrombosis.[1] 
 
The advent of Highly Active Antiretroviral Therapy (HAART) means that more people who 
are infected with HIV will be living longer on antiretroviral treatment. This may increase the 
prevalence of DVT in the population. This apparent increased incidence and prevalence of 
thrombotic episodes among the HIV infected population has a lot of implications for the 
health system e.g. in terms of morbidity, mortality and cost. It is also a source of psychosocial 
problems for the patients who have to be admitted during the acute stage and have to present 
to follow up clinics for many months after discharge. 
 
Not many studies have been conducted to determine the prevalence of DVT among the HIV 
infected population in South Africa and especially in my own part of the country. Such a 
study would therefore be of fundamental importance to determine the true prevalence of DVT 
in the HIV infected population who present to the Nelson Mandela hospital. 
 
From anecdotal experience in the medical ward of Nelson Mandela Hospital, there is a 
tendency to offer HCT to patients with DVT so as to utilize the opportunity to start them on 
ARV treatment in case they are HIV infected, but this is not enough. A study conducted to 
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establish the true prevalence of DVT among the HIV infected population may give us a 
scientific basis to offer VCT routinely to patients admitted with DVT. 
Almost all past studies are retrospective and are able to demonstrate only association between 
HIV and thrombosis with very few formal studies on DVT. A study to establish the 
prevalence of DVT among HIV infected population might stimulate people to conduct a 
prospective study to formally investigate the relationship between DVT and HIV. 
 
With the rising cost of health in the country, it means that any efforts at developing effective 
prophylaxis against DVT and thrombosis at other sites will help reduce the cost of health 
especially when you consider the population of HIV infected people and the high cost 
involved in Antiretroviral drugs and TB treatment. A study to establish the prevalence of 
DVT among HIV infected people might be useful as a basis to advise our HIV/AIDS patients 
on the need to avoid and be aware of risk factors of thrombosis like oral contraceptives pills 
etc. 
This study may serve as a stimulus for more definitive research seeking to establish the 
association between DVT and HIV/AIDS.  Following on such research, formal randomized 
clinical trials might be done to investigate possible effective prophylaxis against DVT as in 
the case of aspirin used as prophylaxis against acute myocardial infarction (AMI) and 
Cerebrovascular Accident (CVA) [23]. 
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CHAPTER TWO 
 
LITERATURE REVIEW 
 
A review of the literature revealed that hematological abnormalities are among the most 
common manifestations of human immunodeficiency virus [HIV] infection and acquired 
immune deficiency syndrome [AIDS]. Saif and Greenberg [1] in their review article reported  
thromboembolic  disease among HIV patients who had no clear cut  general risk factors such 
as surgery, trauma, stasis, nephritic syndrome, pregnancy, or other medical conditions 
associated with thrombus formation. In addition, various abnormalities leading to a 
hypercoagulable state have been detected in HIV patients who had thrombotic disease. [1; 2; 
3; 4;5;6;7] Such abnormalities consistent with a hypercoagulable state include: presence of 
antiphospholipid antibodies and lupus anticoagulant, increased levels of von Willebrand 
factor and d-dimer, deficiencies of protein C , protein S, antithrombin,and heparin cofactor II, 
Disorders of plasmin;increased levels of plasminogen activator inhibitor has been reported in 
HIV–infected patients, predisposing to thromboembolism. These abnormalities correlate with 
the severity of HIV associated immunosuppression as evidenced by the CD4 cell counts. 
 
However, there are other factors that can predispose HIV/AIDS patients to thrombosis such 
as: 
 HIV related nephropathy; presents with nephrotic syndrome with associated disorders 
of hemostasis resulting in thrombotic events. [1]
 
 Immobilization in HIV patients who are sick and confined to bed [1] 
 Immunologic diseases; HIV associated autoimmune hemolytic anemia has been 
associated with an increased risk of thromboembolism. The underlying mechanism is 
unclear. [1]
 
 The presence of protease inhibitors; [1] 
 HIV –associated malignancy and myeloproliferative disorders. 
 Patients who develop deep venous thrombosis with no identifiable risk factors  
             may have an underlying occult malignancy. [1; 8]
 
 AIDS –related malignancies include KS,NHL[B cell], anal carcinoma and  
            cervical carcinoma
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Numerous investigators have proposed various mechanisms to explain the thromboembolic 
events in HIV/AIDS patients. These include: 
[i] Endothelial injury. [1; 9]As evidenced by increased levels of von Willebrand factor 
and total antigenic protein S in the blood of HIV/AIDS patients. 
[ii] Endothelial cell infection by HIV 1 may contribute to vascular disease by causing 
vascular thrombosis and endothelial proliferation. [1; 8]
 
[iii] Low –grade DIC; [1; 9]. This is supported by elevated levels of d-dimers and 
decreased levels of both functional and antigenic protein C 
[iv] Protease inhibitors:It is hypothesized that protease inhibitors may interfere with 
hepatic regulation of the thrombotic proteins, leading to a prothrombotic state in some 
patients. [1; 8]
 
 
Many aspects of acquired immunodeficiency syndrome [AIDS have been described in detail 
in the literature. However, there has been very few articles on the phenomenon of Deep Vein 
Thrombosis [DVT] in the lower extremities of human immunodeficiency virus [HIV/AIDS] 
infected patients. Thrombosis in general remains uncommon [10] and arterial thrombosis 
occurs much rarer although it has been described in patients with HIV/AIDS infection. [11]
 
 
Of note is a retrospective study conducted by Saber AA et al [5] to record the incidence of 
DVT in HIV/AIDS patients and the risk of development of embolic events and to emphasize 
the need for prevention and for the vigorous treatment of this complication.From the study, 
they concluded that HIV/AIDS infection is a considerable risk for the development of DVT 
in the lower extremity. Also, statistically, DVT in HIV/AIDS is approximately 10 times 
greater than in the general population.  
 
Saif MW. et al [8] in their article” AIDS and Thrombosis: Retrospective study of 131 HIV-
Infected patients”   aimed to study the incidence of thrombosis in patients infected with HIV , 
and to assess the correlation of thrombosis with the degree of immunosuppression as well as 
the association with active illnesses and neoplasm. The result of this study suggests that 
AIDS appear to predispose to thrombosis. It also revealed a significant correlation between 
thrombotic disease and CD4 counts(less than 200/mm3) as well as the presence of 
opportunistic infections, AIDS related- neoplasm, or autoimmune disorders associated with 
HIV such as AIHA. In addition Jacobson MC et al, [9] in their article “ Thrombotic  
complications in patients infected with HIV in the Era of Highly Active Anti retroviral 
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Therapy (HAART): A Case Series”, concluded that patients in this series were characterized 
by a relatively young age at the time of thrombosis, a predominance of elevated levels of 
lipids, a history of malignancy, and an advanced CDC HIV classification but not by a low 
CD4 cell count or an elevated HIV load.  
 
A study by Levine et al [12] sought to determine if advancing stages of HIV were associated 
with coagulation abnormalities that could predispose to venous thrombosis .They found 
progressive decreases in protein S and step wise increases in factor VIII with advancing 
stages of HIV. Thus providing a possible biologic mechanism for the increased prevalence of 
venous thrombosis in HIV. Similar study by Matthias E et al [13] found deficiencies of 
protein S and protein C in patients with opportunistic infections, which later improved with 
treatment of the opportunistic infections. 
 
Bayer et al [14] in their study reported a case of bilateral subclavian vein thrombi which 
developed in the presence of a Groshong catheter in a patient with AIDS and disseminated 
cytomegalovirus infection. Similar to this is the case of cerebral venous thrombosis and dual 
primary infection with human immunodefiency virus and cytomegalovirus reported by 
Rouzioux C et al (1989) [15].They found an elevated Anti HIV IgG in the CSF of patients 
with cerebral venous thrombosis. In addition the blood to CSF ratio of anti HIV1 IgGtitres 
further suggests that HIV1 may be the causative agent. 
 
An interesting study was conducted by Lijfering et al [16] to determine the absolute risk of 
venous and arterial thrombosis in HIV infected patients and effects of combination 
antiretroviral therapy. They found that overall, the absolute risk of venous thrombosis in their 
patients group was 6.5 times higher than reported in the general population, while the 
absolute risk of venous thrombosis in patients not using combination antiretroviral therapy 
was still approximately 6 fold higher compared to the general population. Micieli E et al [17] 
conducted a case control study to compare the prevalence of thromboembolic events between 
HIV-positive and HIV–negative individuals. Their results lead to a hypothesis that HIV–
positive patients have an increased risk of thromboembolic disorders. 
 
Another interesting case report was written by Ronald A et al [18].They documented the case 
of a 35 year old African woman with HIV infection and Systemic lupus erythematosus who 
developed recurrent episodes of DVT( 4 episodes) and  pulmonary embolism in the presence 
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of  antiprothrombin antibodies. They concluded that immunological reconstitution in HIV 
infected patients contributes to the appearance of multiple autoimmune conditions including 
SLE and Anti phospholipids syndrome. 
 
In a case control study to investigate the prevalence of established risk factors for venous 
thromboembolism and other risk factors among cohort of HIV infected patients in 
JohnsHopkins university AIDS service, it was found that the incidence of VTE was 0.54% 
which is similar to what other researchers have reported [2]. They also found that patients 
with VTE had lower CD4 counts. Also independent risk factors for VTE that was found 
includes age and hospitalization in the past three months. Of importance is the fact that they 
did not find any association between use of highly active antiretroviral therapy and VTE.-
Ahonkhai AA et al. [19] 
 
Fadi M, AbdoYY and Paul DS [20] conducted a study to determine the incidence of VTE in 
patients with HIV infection and those without HIV infection. Theyanalyzed data from the 
National hospital discharge survey from 1990 through 2005.Among hospitalized patients 
with HIV infection, they found that the incidence of pulmonary (PE) was 0.4%,deep venous 
thrombosis(DVT), 1.4% and VTE,1.7%.They also found that the relative risks compared with 
all hospitalized non – HIV patients of PE,DVT and VTE were 0.91, 1.26 and 1.21 
respectively. That will support the observation that HIV in a way predisposes infected people 
to thromboembolic events. 
 
Although many authors have mentioned many factors as predisposing to thromboembolic 
events in HIV infected patients, the study done by Lijfering WM et al [21] demonstrated how 
progression from HIV infection to AIDS actually affect the level of the commonly mentioned 
risk factors like factor C and factor S deficiency etc.In their study, they recruited 109 
consecutive HIV infected patients in their study. The patients were tested twice for currently 
known thrombophilic abnormalities at an interval of at least 3 months.Repeated 
measurements established protein C deficiency in 9% of the patients, increased factor VIII 
concentration in 41%, high fibrinogen concentrations in 22%, and free protein S deficiency in 
60%. In addition they found that median factor VIII concentrations were higher in patients 
with AIDS than in patients with a non – AIDS defining illness whereas median free protein S 
concentrations were lower. They concluded that multiple acquired and persistent 
thrombophilic abnormalities are more frequently observed in HIV infected patients than in 
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the healthy population. The frequencies of these thombophilic abnormalities increase with the 
progression to AIDS and these findings may contribute to the high prevalence of venous and 
to a lesser extent arterial thrombosis in HIV infected patients. [21]
 
 
LijferingWM [16] also pointed to the fact that the combination of high factor VIII and 
fibrinogen concentrations and decreased free protein S concentrations has been reported in 
patients with systemic lupus erythromatosus and other autoimmune diseases, in patients with 
cytomegalovirus infection and in patients with the nephritic syndrome which are all 
conditions that are associated with an increased risk of venous and arterial thrombosis. Also 
the finding that the development of AIDS was associated with increasing thrombophilic 
abnormalities may have clinical relevance. This is because since HAART is used for long 
term immunologic reconstitution, it may improve these thrombophilic abnormalities and lead 
to a decreased risk of venous and arterial thrombosis. 
 
According to Eyal A and Veller M [22],the first isolated case report of the association 
between venous thromboembolism(VTE) and HIV infection started   to appear in the late 
1980s. Over the years, the association has now  been conclusively proven by a large number 
of studies. They mentioned the first significant study by Hassell et al (1994) which reported 
an incidence of deep vein thrombosis (DVT) of 18% in a group of 60 HIV positive patients. 
A systematic review published in 2005 found an incidence ranging from 0.19% to 18%.This 
is said to be in excess of what one will expect in a non infected population where the average 
risk of developing DVT is reported to be approximately 5/10000. Eyal A and Veller M [22] 
mentioned an audit performed at Johannesburg hospital South Africa in which 84% of 
patients who presented with DVT were found to be HIV positive. This is of importance in 
South Africa when we consider the high burden of HIV in the country. They referred to the 
study by Laing et al (1996) which found that the incidence of DVT was twice as high in 
patients with AIDS as in those with HIV infection without manifestations of AIDS. 
 
Deep vein thrombosis (DVT) has been reported to be more common among HIV infected 
people in several parts of the country. No formal research has been published to confirm or 
refute this observation within the South African context. There has thus been the need to 
determine the prevalence of deep vein thrombosis among patients with HIV infection in the 
medical ward of Nelson Mandela Hospital, Mthatha, South Africa. 
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CHAPTER THREE 
 
AIM 
To determine the prevalence of Deep Vein Thrombosis (DVT) among patients with 
HIV/AIDS  at Nelson Mandela Academic Hospital in Umtata, South Africa and their risk 
profile. 
. 
OBJECTIVES 
The main objectives of this study are: 
 To determine the proportion of patients admitted with DVT who also had HIV/AIDS   
 To obtain a profile of the risk factors associated with DVT in patients requiring 
admission for DVT. 
 To describe the association of DVT and HIV/AIDS in subgroups of patients with 
different degrees of immunosuppression. 
 
METHODS 
Setting of the study 
The study was conducted in the medical ward of Nelson Mandela Academic Hospital, 
Mthatha, Eastern Cape, South Africa. Umtata is the capital of the Transkei region of the 
Eastern Cape Province in South Africa with an estimated population of about one million 
people. Nelson Mandela Academic hospital is a tertiary hospital and renders specialist 
services to other district hospitals and clinics in the area. It has about 600 beds and large 
population of doctors which range from interns to specialists in various fields. It also renders 
services in other health related fields like physiotherapy, speechtherapy, occupational therapy 
etc. 
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Study design: 
 
The study design most appropriate for this research is an observational cross-sectional study. 
 
Inclusion and exclusion criteria 
Inclusion criteria: 
(1) All DVT cases diagnosed by Doppler who were admitted over  the past one year 
(2009) 
(2) All patients who were recorded as being diagnosed HIV positive and admitted over 
the past one year (2009) 
(3) DVT  affecting only the lower limbs 
Exclusion criteria: 
(1) Patients with only clinical diagnosis of DVT. 
 
Ethical consideration 
 
Permission to conduct the study was obtained from the Nelson Mandela Academic Hospital 
authority. (Annexure 3). 
 
Method of data collection 
 
HIV is a major predisposing factor to DVT, as is documented in the literature review, but 
there are also other significant factors that could cause DVT either independently or in 
association with HIV. HCT is being done in our medical ward routinely for patients admitted 
with DVT as part of the screening process for the possible aetiology of the DVT in an attempt 
to ensure that effective and appropriate treatments are administered to patients on an 
individual basis. The health practitioners want to get HIV patients at early stage before they 
develop serious complications of AIDS. An attempt is therefore made to offer HCT to our 
patient as long as there is an indication whether it is serious or not. 
 
All DVT cases were diagnosed by Doppler study which has high sensitivity and specificity 
for diagnosing thrombosis. HIV was diagnosed using the Elisa+ Antigen method, which 
significantly reduces the window period in HIV. It has high reliability and validity 
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Other variables such as age, immobility, pregnancy and pueperium, medication like 
oestrogen, previous DVT, family history etc were obtained from the admission files  but the 
reliability cannot be ensured. See checklist Annexure 1. Other variables like the presence of 
obesity, varicose veins, infections, malignancy, recent myocardial infarction, nephrotic 
syndrome, haematological abnormalities etc, were also obtained from physical examination 
and laboratory investigations recorded in the files. See checklist and data extraction schedule, 
annexure 1 and 2 respectively. 
 
Pilot study 
 
A pilot study was conducted on 5-10 patients’ charts in the ward in an attempt to clarify 
ambiguity and improve on the logistics and layout of the research instrument. 
 
Collection of data 
 
The researcher collected all data mostly from the patients’ case notes on the ward, Annexure 
2. All DVT patients were formally diagnosed by Doppler studies and HIV tested voluntarily 
using Elisa + Antigen method. All new DVT admissions are normally assessed on a daily 
basis until discharge. Even after discharge from the ward, they are normally referred to the 
hematology clinic where the effectiveness of anticoagulation agent ismonitored. A total 
number of 102 DVT cases were collected which were admitted over a one year period. 
 
Statistical Analysis 
 
Data were   analyzed by a statistician at the Walter Sisulu University  using appropriate 
descriptive statistics. Two main groups of DVT in HIV negative patients and DVT in HIV 
positive patients were analyzed to determine proportions and frequencies and to conduct 
further subgroup analysis as indicated in the objectives of the study. 
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CHAPTER FOUR 
 
RESULTS AND ANALYSIS 
 
A total no of 102 DVT cases were collected from the chart review over the past one year. A 
total of 81 (79.4%) of the DVT cases were also HIV infected while 21 (20.6%) of the DVT 
cases were HIV negative. It is of importance to note that most of the DVT cases 86(84.3%) 
were females while only 16 (15.7%) were males. Only 41(50.6%) of the HIV positive cases 
had their CD4 counts recorded in the charts. Out of these 41 cases, 29 (70.7%) cases had CD4 
counts < 200 while 12 (29.3%) had CD4 counts ≥ 200. A total of 56 DVT cases had their full 
blood counts results recorded in the charts. Out of these,47 (83.9%) had platelets ≥ 150 000 
while only 9 (16.1%) cases had platelets counts < 150 000.Out of the 81 cases of DVT with 
HIV infection, only 25 (30.9%) of them were on HAART.When we consider the data on 
other risk factors for DVT, only TB had a significant number of people,42 (41.2%) being co 
infected. We also found that most of the people with DVT, 70 (68.6%) are < 40yrs while only 
32 (31.4%) are ≥ 40yrs.See Table 1. 
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TABLE 1 
 
CLINICAL CHARACTERISTICS OF PATIENTS WITH DVT (n = 102) 
Characteristic    n(% ) or  Median (Range ) 
Sex 
Male                                                                                                               16 (15.7%) 
Female                                                                                                           86 (84.3%) 
Leg 
Right                                                                                                               44 (43.1%) 
Left                                                                                                                  58 (56.9%) 
HIV 
Positive                                                                                                           81 (79.4%) 
Negative                                                                                                         21 (20.6%) 
CD4 count 
< 200                                                                                                               29 (70.7%) 
≥ 200                                                                                                                12 (29.3%) 
Platelets 
< 150 000                                                                                                         9 (16.1%) 
≥ 150 000                                                                                                        47 (83.9%) 
HAART 
Yes                                                                                                                    26 (32 .1%) 
No                                                                                                                     55 (67.9%) 
Obesity 
Yes                                                                                                                    7 (6.9%) 
No                                                                                                                     95 (93.1%) 
Smoking 
Yes                                                                                                                    4 (3.9%) 
No                                                                                                                     98 (96.1%) 
Tuberculosis 
Yes                                                                                                                      42 (41.2%) 
No                                                                                                                       60 (58.8%) 
Pregnancy 
Yes                                                                                                                       10 (9.8%) 
No                                                                                                                        92 (90.2%) 
Immobility 
Yes                                                                                                                        6 (5.9%) 
No                                                                                                                         96  (94.1%) 
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Contraceptives 
Yes                                                                                                                        4 (3.9%) 
No                                                                                                                         98  (96.1%) 
Diabetes 
Yes                                                                                                                        8 (7.8%) 
No                                                                                                                         94  (92.2%) 
Hypertension 
Yes                                                                                                                        8 (7.8%) 
No                                                                                                                         94  (92.2%) 
Cancer 
Yes                                                                                                                        3 (2.9%) 
No                                                                                                                         99  (97.1%) 
Cardiac 
Yes                                                                                                                         4 (3.9%) 
No                                                                                                                          98(96.1%) 
Kidney 
Yes                                                                                                                          1 (1.0%) 
No                                                                                                                           101 (99%) 
Age 
< 40yrs                                                                                                                    70  (68.6%) 
≥ 40yrs                                                                                                                    32 (31.4%) 
 
The data was analyzed using SPSS software, version 18. Chi square test was used as test of 
hypothesis and unconditional logistic regression was used to adjust for the effect of 
confounding factors. 
 
From the analysis, when individual risk factors were considered separately, people < than 
40yrs which constituted 68.6% of DVT cases had OR = 1.979 (95% CI = 0.936 – 4.4.183); 
X
2
 = 3.247 (p = 0.072). HIV is the single most important risk factor for DVT in this study. A 
consideration of the association between HIV and DVT yielded a X
2 
= 36.959 (p = < 0001) 
and OR = 11.571 (4.888 – 27.392) which shows that HIV infected people have more chance 
of having DVT than those who are HIV negative. People with platelets ≥ 150 000 accounted 
for 83.9% of DVT cases with known platelets counts but with X
2
 = 0.096 (P= 0.756) and OR 
= 0.814 (95% CI = 0.221 – 2.992), there is no association between platelets level and 
DVT.Obesity is one of the risk factors for DVT but found in only 6.9% of the DVT cases, X
2
 
= 2.887(P = 0.089), OR = 1.421 (CI = 1.274 – 1.585). Hypertension is found in 7.8% of DVT 
cases but there is no association between DVT and hypertension, X
2
 = 0.749 (p = 0.387);OR 
Stellenbosch University  https://scholar.sun.ac.za
23 
 
= 0.596 (95% CI = 0.183 – 1.944).Cancer is an important risk factor for DVT but only found 
in 2.9% of   the DVT cases. Although the OR = 1.404 (95% CI = 1.263 – 1.561) suggests 
slight increase in the risk of DVT with cancer, the result is not statistically significant, X
2
 = 
1.202 (p = 0.273).People with cardiac disease as co morbidity accounted for 3.9% of DVT 
cases but there is no association between DVT and cardiac disease, X
2
 = 0.785 (p= 0.376); 
OR = 0.503 (95% CI = 0.107 – 2.358). Kidney disease was found in only 1% of DVT cases 
and there is no association between kidney disease and DVT from the analysis, X
2 
= 2.245 (p 
= 0.134);OR = 0.188 (95% CI = 0.017 – 2.135). (Table 2) 
 
We have mentioned that females accounted for  84.3% of DVT cases but when subjected to 
statistical analysis, sex did not show any association with DVT,X
2
 = 1.666(P = 0.197),OR = 
0.558 (95% CI = 0.229 – 1.363).From the results, despite the fact that smoking is found in 
only 3.9% of DVT cases, with X
2
 = 19.544 ( p = < 0.0001) and OR = 0.095 (95% CI = 0.028 
– 0.318), the result is statistically significant. As has been mentioned before, 41.2% of the 
DVT cases were also co infected with Tuberculosis. The analysis showed that people with 
TB have higher chance of developing DVT than others with X
2
= 23.388 (P = < 0.0001) and 
OR = 1.667 (95% CI = 1.420 – 1.956).Not many of the DVT cases were immobile before 
they developed DVT (5.9%).Although the OR = 1.417(95% CI = 1.271 – 1.579) suggest 
slight risk of developing DVT when immobile, the result is not statistically significant, X
2
 = 
2.457 (P = 0.117).Diabetes was found in 7.8% of DVT cases but there was no association 
between Diabetes and DVT,X
2
 = 1.656 (P = 0.198); OR = 0.482 (95% CI = 0.156 – 
1.491).(table 2) 
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TABLE 2 
UNIVARIATE      ANALYSIS     RESULTS 
 
Variable                                                      X
2
 (p value)                      OR (Confidence Interval) 
< 40yrs                                                        3.247 (0.072)                    1.979 (0.936 – 4.183) 
HIV                                                            36.959 (0.000)                   11.571(4.888 – 27.392) 
Platelets>150000                                        0.096 (0.756)                     0.814 (0.221 – 2.992) 
Obesity                                                       2.887 (0.089)                    1.421 (1.274 – 1.585) 
Hypertension                                              0.749 (0.387)                    0.596 (0.183 – 1.944) 
Cancer                                                        1.202 (0.273)                    1.404 (1.263 – 1.561) 
Cardiac                                                       0.785 (0.376)                    0.503 (0.107 – 2.358) 
Kidney disease                                           2.245 (0.134)                   0.188 (0.017 – 2.135) 
Sex                                                             1.666 (0.197)                    0.558 (0.229 – 1.363) 
Smoking                                                    19.544 (0.000)                  0.095 (0.028 -0.318) 
Tuberculosis                                              23.388 (0.000)                  1.667 (1.420 – 1.956) 
Immobility                                                 2.457 (0.117)                    1.417 (1.271 – 1.579) 
Diabetes                                                   1.656 (0.198)                     0.482 (0.156 – 1.491) 
 
LOGISTIC REGRESSION 
 
When the effects of confounding factors were analyzed by logistic regression,HIV infection 
was identified as the most significant and independent determinant of the presence of DVT 
after adjusting for TB, sex,age,obesity,diabetes,cancer and immobility. Thus the risk of DVT 
was multiplied by 12 (OR = 11.6,95% CI = 4.9 – 27.3); p = < 0.0001; Beta coefficient = 
2.449; Standard error = 0.440 and Wald chi square = 31.016. Also age < 40years showed as 
significant and independent determinant of DVT with OR = 2.7 (95% CI = 1.1 - 6.7); p = 
0.034. (Table 3) 
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TABLE   3 
 
SIGNIFICANT AND INDEPENDENT DETERMINANTS OF DVT 
 
 B coefficient       Standard 
Error     
Wald  
chi square   
OR (95% CI) P value 
Independent 
variables 
     
 
Age groups 
     
 
Age< 40 yrs 
 
 
0.989 
 
0.466 
 
4.509 
 
2.7 (1.1-6.7) 
 
0.034 
      
 
HIV positive 
 
 
2.574 
 
0.462 
 
30.984 
 
13.2 (5.3-32.3 
 
< 0.0001 
      
Constant 1.021 0.438 5.434  0.020 
After adjusting for sex, obesity, immobility, diabetes and cancer 
Y =  1.021 + 2.574 HIV    +  0.989 Age group 
 
 
Out of the 650 HIV related cases admitted in the medical department over a year period 
according to the records, 81 were documented DVT and HIV cases which gave a prevalence 
of DVT = 12.5%. This is above the average of 1% to 2% normally reported in most studies 
[19; 20]. But, some studies have reported incidence as high as 18% among HIV population. 
[22]  
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CHAPTER FIVE 
 
DISCUSSION 
 
HIV predisposes to hypercoagulable state and the prevalence of DVT among HIV population 
at Nelson Mandela Hospital of 12.5%  together with the results of OR and chi square for 
DVT and HIV further confirm the association between HIV and DVT recorded in various 
studies. This is in agreement with what researchers [22] have mentioned. Eighty one (79.4%) 
of the DVT cases also had HIV.This is close to the proportion of 84% found at Johannesburg 
hospital. [22] Various researchers [8; 12; 21] have also mentioned that progression to AIDS 
or lower CD4 counts also makes patients more susceptible to DVT.This is also confirmed in 
our study which found that among the 41 people whose CD4 counts were known, 70.7% of 
them have CD4 counts less than 200 and 29.3% have CD4 counts more than 200.This is 
important when prophylaxis measure to prevent DVT in HIV population is being considered. 
In the study, females were more affected than males 86 vs. 16.This could be attributed to the 
fact that females are more at risk of HIV infection from heterosexual relationship and also are 
the only one  prone to unique risk factors like oral contraceptives pills  and pregnancy. 
Though in our study, only 4 females were on contraceptives. It is expected that higher 
platelets counts will predispose to DVT but despite the fact that 47 people(out of 56 people 
with known platelets) had platelets count ≥ 150 000, there was no association between 
platelets counts and DVT in both univariate and multivariate analysis. Of importance is the 
fact that most of the people with DVT are <40yrs (70 people).These are generally the age 
group with the highest risk of HIV transmission. Studies such
 
as [8] also found that 
thrombosis is more common in younger age group. This could be attributed to the fact that 
common risk factors for DVT like HIV, pregnancy, oral contraceptives pills etc are more 
common in this age group (Table 1). 
 
From the analysis, when individual risk factors were considered separately, people < than 
40yrs which constituted 68.6% of DVT cases had OR = 1.979 (95% CI = 0.936 – 4.4.183); 
X
2
 = 3.247 (p = 0.072).Although the OR suggests that people < 40yrs have almost double the 
risk of having DVT compared with those ≥ 40yrs, the result is not statistically significant 
when you consider the CI and the p values. 
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Tuberculosis is the most common opportunistic infection among HIV infected population and 
also a risk factor for DVT. [8] It is therefore not surprising that 42 of the patients were also 
on TB treatment. In univariate analysis, TB predisposed to DVT, X
2
 = 23.388 (p = < 0.0001), 
OR = 1.667 (95% CI = 1.420 – 1.956) but in multiple logistic regression, it did not show any 
association with DVT. However, as it has been mentioned above just as HIV infection 
predisposes to TB, Tuberculosis also worsens HIV infection leading to reduction in CD4 
counts. This might be important when considering which patients are candidates for DVT 
prophylaxis. Only 3.9% of the DVT cases were smokers. Considering the fact that most of 
the DVT cases (79.4%) were HIV infected, they could have stopped smoking when their 
health condition deteriorated from AIDS. Also since most of the patients were females, this 
could have reduced the prevalence of smoking in the study since there are more smokers 
among males than females. From the results, despite the fact that smoking is found in only 
3.9% of DVT cases, with X
2
 = 19.544 ( p = < 0.0001) and OR = 0.095 (95% CI = 0.028 – 
0.318), smoking seems to have protective effect against DVT and the result is statistically 
significant. This is the opposite of what is expected with respect to smoking and DVT. 
Because of the age group of < 40yrs mostly having DVT, diseases like Diabetes and 
Hypertension are less prevalent and hence did not show any association with DVT. 
Immobility was found in only 5.9% of the DVT cases. Although the OR = 1.417 (95% CI = 
1.271 – 1.579) showed that people who were immobile had higher chance of developing 
DVT, the result was not statistically significant (p = 0.117).This means that the result could 
be a chance finding. But we should also consider that fact that because of recall bias, many of 
the patients might not have remembered accurately if they had a few days of physical 
inactivity prior to the onset of DVT or not. In addition because these patients are now used to 
being less physically active because of their health condition, they might not recognize it as 
an abnormality that could be responsible for the DVT. 
 
Out of 81 cases of DVT with HIV infection, only 25(30.9%) were on HAART.When we 
consider the fact that 70.7% of 41 cases with known CD4 counts had CD4≤ 200, there is thus 
the possibility that more of those patients with DVT who are HIV infected could have 
benefitted from HAART.However, one will also need to consider why those on HAART 
(30.9%) also had DVT since HAART is expected to improve the CD4 counts and reduce the 
occurrence of conditions like DVT, tuberculosis, etc. In this regard, the issue of compliance, 
treatment failure, associated risk factors for DVT etc will need to be considered. Furthermore, 
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we did not have information on when the patients started HAART and the initial CD4 counts. 
Also we are not sure of what regimen they were on  and at what dosage since it has been 
found that not all medical practioners (especially general practioners) have adequate training 
in prescribing HAART. 
 
Obesity is one of the risk factors for DVT but found in only 6.9% of the DVT cases, X
2
 = 
2.887(P = 0.089), OR = 1.421 (CI = 1.274 – 1.585).There is really no significant association 
between DVT and obesity although the OR suggest there is a small risk of DVT  with 
obesity. This means that the association could have been a chance finding.With 79.4% of the 
DVT cases being HIV infected, weight loss would probably have being a more prominent 
feature. People with HIV/AIDS tend to have chronic diarrhea, loss of appetite etc.Sometimes 
when they don’t have jobs and they are not on grants, they have little or no food to eat. 
Out of the 650 HIV related cases admitted in the medical department over a year period 
according to the records, 81 were documented DVT and HIV cases which gave a prevalence 
of DVT = 12.5%.This is above the average of 1% to 2% normally reported in most studies 
[19; 20]. But, some studies have reported incidence as high as 18% among HIV population. 
[22]. However, it is important to know that because of poor record keeping, the number of  
HIV related admissions could have been under reported and which could be responsible for 
the higher than average prevalence of DVT in the hospital. 
 
 
Clinical Outcomes: 
 
Overall, there was no mortality due to complications of DVT (i.e. pulmonary embolism) 
among all the 102 patients admitted with DVT over the 12 months period while they were on 
admission. Most of the patients were discharged within two weeks of admission unless they 
had other co morbidities which necessitated longer stay on the ward. 
 
RECOMMENDATIONS 
 
It was found from the study that the risk for DVT among HIV/AIDS patients is 
approximately 12 times higher than that of the general population.
 
With the advent of 
HAART, more people with HIV/AIDS will survive into old age and that means that the rate 
of thromboembolic episodes will further increase. So there is need to identify the common 
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pathway to thrombosis in this population from all the various risk factors identified. When 
the pathway is understood, it can then be possible to develop or administer appropriate 
prophylaxis measures for  at risk patients either within the hospital set up (e.g. heparin) or for 
high risk out patients (e.g. anti – inflammatory or anti platelets agents). 
 
During this study, the researcher discovered that our DVT cases were not adequately 
investigated especially in terms of biochemical tests. Hence information about protein C, 
protein S, antithrombin III, CMV infection etc were not available. These deficiencies were 
due to limited financial support from the government which limits health practitioners to 
ordering only the most essential investigations needed for patients’ care. It is therefore 
important for government to make money and other resources available for detailed research 
into issues related to HIV in order to be able to offer the best management to our HIV 
patients. This is important when one consider the million of South Africans who are HIV 
infected and the bulk of which are in the productive age groups. 
 
There is need for proper record keeping in our health institutions so that we can have data 
that are as accurate as possible in order for them to produce results that can be useful for the 
population when they are used for research. 
 
Finally from our study, we found that most of the people with CD4 less than 200 (14) but 
who were not on HAART were referred from the clinics and district hospitals without ARV 
facility. Therefore it is important for the government to make ARVs available in all the health 
institutions. 
 
CONCLUSION 
 
The prevalence of DVT at the Nelson Mandela hospital Mthatha was 12.5% for the year 2009 
and is similar to that reported in other studies although above the average reported. HIV 
infection and age were the risk factors with a statistically significant association with DVT in 
this study. As this was an observational cross-sectional study, a more definitive prospective 
longitudinal design would assist in establishing the incidence of DVT in HIV infected 
patients, as well as the magnitude of the relationship between HIV and DVT. 
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ANNEXURE 1 (CHECKLIST) 
 Age: 
 
 Gender: 
M F 
 
 Obesity: 
YES NO 
  
 
                -Height: 
 
 
                      -Weight: 
 
 
                      -Body Mass Index (BMI): 
 
 
 Varicose veins: 
YES NO UNSURE 
   
 Surgical treatment  of varicose veins: 
YES NO UNSURE 
   
 
 Opportunistic infections: 
- Confirmed  Tuberculosis: 
 YES NO UNSURE 
X-ray findings    
Sputum    
Cerebrospinal fluid    
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Abdominal Ultrasound    
Tissue biopsy    
On treatment    
 
       - Confirmed Pneumocystis carinii pneumonia: 
 YES NO UNSURE 
X-ray findings    
Clinical diagnosis    
On treatment    
 
 Confirmed  Malignancy: 
 YES NO UNSURE 
History    
Pathology report    
 Type of malignancy: 
 
 Smoking: 
YES NO 
  
 
            -Severity of smoking: 
Less than 10 /day 10-20 /day More than 20 /day 
   
 
 Confirmed  recent myocardial infarction: 
 YES NO UNSURE 
Troponin  T    
ECG findings    
History    
 
 -Time of diagnosis of myocardial infarction: 
Less than 2 weeks 2weeks-1 month 1 month – 3 months More than 3 months 
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 Confirmed  Nephrotic syndrome: 
                    -Proteinuria: 
None Trace/ 1+ 2+ 3+ 4+ 
     
 -Others: 
 YES NO UNSURE 
Clinical findings    
On treatment    
 
 Confirmed  Diabetes Mellitus: 
 YES NO UNSURE 
Blood sugar    
On treatment    
                 - HbA1c: 
Less than 7 7- 10 More than 10 
   
 
 Confirmed  Hypertension: 
 YES NO UNSURE 
Hypertension    
On treatment    
- Systolic  blood pressure: 
 140-160 mmHg 161-180 mmHg More than 180 mmHg 
Systolic    
- Diastolic blood pressure: 
 90-100 mmHg 101-110 mmHg More than 110 mmHg 
Diastolic    
 Immobility: 
 YES NO 
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                       -Duration of Immobility: 
1- 4 days 5 days- 1 week 1-2 weeks 2-4 weeks More than 4 
weeks 
     
 
 Hormone replacement therapy: 
 YES NO 
   
                        -Duration of Hormone replacement therapy: 
Less than 1 month 1-3 months 4-6 months more than 6 months 
    
 Oral contraceptives: 
 YES  NO 
   
                       -Duration of Oral contraceptives: 
Less than 1 month 1-3 months 4-6 months more than 6 months 
    
 Pregnancy and Pueperium: 
 YES NO 
   
 Previous Deep Vein Thrombosis: (DVT) 
 YES NO 
   
 Family history of Deep Vein Thrombosis: (DVT) 
 YES NO 
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ANNEXURE 2 (EXTRACTION SCHEDULE) 
Code number: 
 
Date: 
 
Height (meters): 
 
Weight (kg): 
 
Main complaints: 
 
Risk factors from annexure 1: 
 
Doppler findings: 
Positive;                                               Negative                                            Unsure 
HIV result: 
 YES NO UNAVAILABLE 
HIV    
CD4 counts: 
 Normal 200-500 Less than 200 
    
FBC: 
MCV WCC Hb Platelets 
    
Blood sugar: 
 
Troponin T: 
 
ECG findings: 
 
Urinalysis: 
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ANNEXURE 3: LETTER OF APPROVAL 
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